ARTICLE | Company News
MEDX, Xerion antibody deal
January 20, 2004 8:00 AM UTC
Medarex (MEDX) and Xerion (Munich, Germany) partnered to develop human antibodies. Under the deal, Xerion will use its Xstream technology to identify targets, against which MEDX will use its UltiMab H...